Publication | Closed Access

Cobimetinib combined with vemurafenib in advanced BRAFV600-mutant melanoma (coBRIM): updated efficacy results from a randomised, double-blind, phase 3 trial

MedicineAdvanced Brafv600-mutant MelanomaMelanomaImmune Checkpoint InhibitorDermatologyOncologyRadiation OncologyNovel TherapyMolecular OncologyEfficacy Results